Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Rats had lasting erectile problems after stopping a certain medication.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Finasteride capsules with nanoparticles improve drug delivery, solubility, stability, and effectiveness.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Commercial hair loss websites promote Propecia by making men feel insecure about baldness and suggesting it's a medical issue needing treatment.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Desolvation of finasteride depends on environment and technique.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.